Literature DB >> 8749032

Serotonergic modulation of cat bladder function before and after spinal transection.

M J Espey1, J W Downie.   

Abstract

Micturition was evoked in conscious cats by infusing saline into the bladder at a physiological rate. Drugs were administered intrathecally. Micturition volume threshold was increased by 5-hydroxytryptamine (5-HT, serotonin) and decreased by zatosetron, a 5-HT3 receptor antagonist, in spinally intact cats. Thus 5-HT3 receptors inhibit micturition. After complete spinal transection, serotonin reduced volume threshold in 3 of 4 cats, indicating an alteration in serotonergic control. However, 2-methyl-5-HT, a 5-HT3 receptor agonist, increased volume threshold. Thus 5-HT3 receptor-mediated inhibition of bladder function remains after spinal transection. We conclude that some, but not all, serotonergic modulation of bladder function is altered after spinal transection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8749032     DOI: 10.1016/0014-2999(95)00614-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Authors:  Karl-Erik Andersson; Rikard Pehrson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Update on overactive bladder: pharmacologic approaches on the horizon.

Authors:  Eric S Rovner; Alan J Wein
Journal:  Curr Urol Rep       Date:  2003-10       Impact factor: 3.092

Review 3.  The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition.

Authors:  Andrew G Ramage
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Pathophysiology of overactive bladder and urge urinary incontinence.

Authors:  William D Steers
Journal:  Rev Urol       Date:  2002

5.  Involvement of 5-HT3 receptors in pudendal inhibition of bladder overactivity in cats.

Authors:  Zeyad Schwen; Yosuke Matsuta; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-03

6.  Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats.

Authors:  P L Vera; A Miranda-Sousa; I Nadelhaft
Journal:  BMC Pharmacol       Date:  2001-08-31

7.  Stability of the acetic acid-induced bladder irritation model in alpha chloralose-anesthetized female cats.

Authors:  F Aura Kullmann; Grace I Wells; Christopher L Langdale; Jihong Zheng; Karl B Thor
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

Review 8.  Update on duloxetine for the management of stress urinary incontinence.

Authors:  Maya Basu; Jonathan R A Duckett
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

9.  Overactive bladder syndrome pharmacotherapy: future treatment options.

Authors:  Andrzej Wróbel
Journal:  Prz Menopauzalny       Date:  2015-12-16

10.  A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors.

Authors:  Andrzej Wróbel; Aleksandra Szopa; Anna Serefko; Ewa Poleszak
Journal:  Molecules       Date:  2020-03-18       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.